News and Trends 4 Feb 2021
HIV Drug Approvals Lift Hopes Amid Missed UN Targets
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers around the world. However, a…
ViiV Healthcare
- Latest Posts
News and Trends 23 Mar 2020
ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for the treatment of HIV in…
News and Trends 22 Nov 2019
ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed from the National Institutes of…
News and Trends 22 Aug 2019
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen has proven it is as…
ADVERTISEMENT
News and Trends 23 Jul 2019
HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail
A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus in people who have become…
News and Trends 3 Jul 2019
EU Approves Two-Drug Pill as First-Line Treatment for HIV
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as a first-line treatment for HIV,…
News and Trends 4 Apr 2019
Update: Two-Drug HIV Treatment Effective for up to Three Years
Update (04/04/2019): ViiV Healthcare's two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for up to three years in…
News and Trends 11 Mar 2019
Monthly Injection Proves as Good as Daily Pills Against HIV in Phase III
Two phase III trials conducted by ViiV Healthcare have concluded that a monthly injection of two anti-HIV drugs is as…
News and Trends 31 Oct 2018
Forget Daily Pills: HIV Could Be Treated With Monthly Injections
A monthly antiviral injection may be as good as daily HIV drugs for suppressing infections, reports the British biotech ViiV…
News and Trends 25 Jul 2018
Two Drugs as Good as Three for Treating HIV
ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the usual three, which have the…
ADVERTISEMENT
News and Trends 8 Feb 2018
GSK’s Company Starts Phase III Trials with Two-Drug HIV Treatment
ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for HIV can work as well…
Infographics 13 Sep 2017
The 10 Most Innovative HIV Treatments to Defeat AIDS
This infographic gathers 10 of the best HIV treatments in Europe's pipeline that will help doctors worldwide fight against AIDS…
News and Trends 14 Feb 2017
Dual HIV Therapy: GSK and Gilead Battle over Whose Drug is the Best
GSK announced Phase III results for dolutegravir, which could reduce triple HIV therapy down to two drugs, but Gilead is…